Health Group Of The Year: Covington & Burling

Law360, New York (January 20, 2012, 8:37 PM EST) -- Attorneys from Covington & Burling LLP’s life sciences group helped Eli Lilly & Co. unravel a long-standing marketing partnership with Amylin Pharmaceuticals Inc. in an arrangement that could net Eli Lilly some $1.6 billion, one of several victories that earned the firm a spot among Law360’s Health Groups of 2011.

Eli Lilly and Amylin had entered into a joint marketing agreement in 2002 to bring the Type 2 diabetes drug exenatide to market. They rolled out the brand name drug Byetta in 2005, and were planning...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.